AnalystsAndrea Tan
Andrea Tan's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 4%
#5032 out of 5217 analysts
Average Return
-6.55%
Win Rate
38%16 out of 42
Risk vs Reward
Poor
Good

Andrea Tan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Insmed IncINSM
+163.18%$24.93$65.61
2024-05-15 -
2025-05-14
Strong Buy
Day One Biopharmaceuticals IncDAWN
+157.37%$8.28$21.31
2025-03-25 -
2026-03-13
Strong Buy
Iovance Biotherapeutics IncIOVA
+105.18%$1.93$3.96
2025-05-12 -
2026-03-13
Strong Buy
Fate Therapeutics IncFATE
+79.03%$14.21$2.98
2022-12-15 -
2023-12-14
Strong Sell
Relmada Therapeutics IncRLMD
+75.07%$2.96$0.74
2024-06-05 -
2025-06-04
Strong Sell

Andrea Tan Analyst Color

Get additional color on Andrea Tan's coverage of popular stocks

Andrea Tan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Krystal Biotech IncKRYS
2Strong Buy$327.00+32.25%Maintains
a month ago
Arrowhead Pharmaceuticals IncARWR
3Hold$85.00+54.41%Maintains
2 months ago
Insmed IncINSM
11Strong Buy$225.00+61.29%Maintains
3 months ago
Iovance Biotherapeutics IncIOVA
7Strong Buy$8.00+102.02%Maintains
10 months ago
Tarsus Pharmaceuticals IncTARS
4Hold$51.00-24.96%Maintains
10 months ago
Day One Biopharmaceuticals IncDAWN
6Strong Buy$27.00+26.70%Maintains
a year ago
Sagimet Biosciences IncSGMT
5Hold$6.00N/AMaintains
2 years ago
Relmada Therapeutics IncRLMD
3Strong Sell$2.00N/ADowngrades
2 years ago
Kodiak Sciences IncKOD
1Strong Sell$2.00N/AReinstates
2 years ago
Immunogen IncIMGN
1Hold$17.00N/AInitiates Coverage On
2 years ago
Abcellera Biologics IncABCL
2Strong Buy$24.00N/AMaintains
3 years ago
Fate Therapeutics IncFATE
2Strong Sell$4.00N/AMaintains
3 years ago
Madrigal Pharmaceuticals IncMDGL
1Strong Buy$375.00N/AMaintains
3 years ago
Verve Therapeutics IncVERV
1Strong Sell$13.00N/AInitiates Coverage On
3 years ago
Codiak Biosciences IncCDAKQ
5Hold$1.40N/AMaintains
3 years ago
Vor Biopharma IncVOR
2Hold$80.00N/AMaintains
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.